Clinical Findings of Pediatric HIV Infection in a Tertiary Center in Turkey

Year 2017, Volume: 34 Issue: 3, 239 - 245, 01.05.2017

Murat Sütçü Manolya Acar Hacer Aktürk Selda Hançerli Torun Hayati Beka Ali Ağaçfidan Nuran Salman Ayper Somer

Abstract

Background: Paediatric HIV infection is different from the adult type of disease in many ways, including transmission routes, clinical findings and treatment strategies. Aims: To evaluate clinical data of paediatric patients with HIV disease. Study Design: Retrospective cross-sectional study. Methods: The charts of 22 paediatric patients diagnosed with HIV infection in our clinic during a 14 year period through 2001-2015 were retrospectively analysed. Clinical data, laboratory findings, treatment modalities and outcomes were recorded. Results: The mean age of diagnosis 61.9±49.2 months and the mean follow-up period was 60.3±37.5 months. Seven patients (31.8%) were foreigners and the most common transmission route was vertical transmission (n=16, 72.7%). The most common presenting symptom and the sign were history of recurrent upper respiratory tract infections (n=8, 36.4%) and lymphadenopathy (n=12, 54.5%), respectively. Recurrent pneumonia (n=6, 27.3%), prolonged fever (n=5, 22.7%), recurrent otitis media (n=4, 18.2%), and gastroenteritis (n=4, 18.2%) were other clinical symptoms. Other than bacterial sinopulmonary infections, tuberculosis was the most frequent opportunistic infection (n=3, 13.6%). Mortality occurred in two patients (9.1%). Conclusion: Although mostly vertically transmitted,  HIV infection  may be diagnosed throughout the childhood. Frequently encountered signs and symptoms may be the reason for doctor admission. High clinical suspicion together with detailed anamnestic data and physical findings constitute the basis for pediatric HIV diagnosis.

Keywords

Child, HIV infection, Turkey

References

• 1. UNAIDS. Gap Report 2014. (English original, July 2014, updated September 2014). Available from http://files.unaids.org/en/media/unaids/contentassets/ documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf
• 2. T.C Sağlık Bakanlığı. HIV/AIDS veri tabloları 01 ekim 1985- 30 haziran 2015. Türkiye Halk Sağlığı Kurumu Bulaşıcı Hastalıklar Daire Başkanlığı Zührevi Hastalıklar Birimi. 26 Şubat 2016. Available from http://www. hatam.hacettepe.edu.tr/veriler_Haziran_2015.pdf
• 3. World Health Organization and UNAIDS. Global AIDS Response Progress Reporting 2015. December 2014, Geneva, Switzerland. Available from http://www.unaids.org/sites/default/files/media_asset/JC2702_ GARPR2015guidelines_en.pdf.
• 4. Siberry GK. Preventing and managing HIV infection in infants, children and adolescents in the United States. Pediatr Rev 2014;35:268-86.
• 5. Prasitsuebsai W, Kariminia A, Puthanakit T, Lumbiganon P, Hansudewechakul R, Siew Moy F, et al. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database. Pediatr Infect Dis J 2014;33:747-52.
• 6. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIVrelated disease in adults and children. Geneva, 2007. Available from http:// www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf
• 7. Stanley F Lo. Reference intervals for laboratory tests and procedures. In: Kiegman RM, Stanton BF, Geme Jw and Schor NF, editors. Nelson Textbook of Pediatrics. Canada 2015:3464-73.
• 8. T.C Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. HIV/AIDS Tanı Tedavi rehberi. Ankara 2013. Available from http://thsk.saglik.gov.tr/ eDosya/bulasici-hastaliklar-db/hiv_aids_tani_tedavi_rehberi_2013.pdf
• 9. Centers for Disease Control and Prevention. HIV Surveillance Report, 2013; vol. 25. Available from http://www.cdc.gov/hiv/library/reports/ surveillance/. Published February 2015. Accessed [date]
• 10. Kariminia A, Chokephaibulkit K, Pang J, Lumbiganon P, Hansudewechakul R, Amin J, et al. Cohort Profile: The TREAT Asia pediatric HIV observational database. Int J Epidemiol 2011;40:15-24.
• 11. Fernández-Ibieta M, Ramos Amador JT, Guillén Martín S, González-Tomé MI, Navarro Gómez M, Iglesias González-Nicolás E, et al. Why are HIVinfected infants still being born in Spain? An Pediatr 2007;67:109-15.
• 12. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland 2000-2006. AIDS 2008;22:973-81.
• 13. Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22:289-99.
• 14. Sütçü M, Aktürk H, Somer A, Hançerli Törün S, İnce Z, Çoban A, et al. Mother-to-child transmisson of HIV: an eight-year experience. Mikrobiyol Bul 2015;49:542-53.
• 15. Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr 2001;38:239-46.
• 16. Shah SR, Tullu MS, Kamat JR. Clinical Profile of Pediatric HIV infection from India. Arch Med Res 2005;36:24-31.
• 17. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol 2007;46(Suppl 2):14-8.
• 18. Basu S, Kumar A. Giant molluscum contagiosum - a clue to the diagnosis of human immunodeficiency virus infection. J Epidemiol Glob Health 2013;3:289-91.
• 19. Van Gend CL, Haadsma ML, Sauer PJ, Schoeman CJ. Evaluation of the WHO clinical case definition for pediatric HIV infection in Bloemfontein, South Africa. J Trop Pediatr 2003;49:143-7.
• 20. Bedri A, Lulseged S. Clinical description of children with HIV/AIDS admitted at a referral hospital in Addis Ababa. Ethiop Med J 2001;39:203-11.
• 21. Spira R, Lepage P, Msellati P, Van De Perre P, Leroy V, Simonon A, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics 1999;104:56.
• 22. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 2003;188:1146-55.
• 23. MacDougall DS. TB & HIV: the deadly intersection. J Int Assoc Physicians AIDS Care 1999;5:20-7.
• 24. Kraussa AM, Harissa DR, Abreub T, Ferreira FG, Ruz NP, Worrell C, et al. Tuberculosis in HIV-infected infants, children, and adolescents in Latin America. Braz Infect Dis 2015;19:23-9.
• 25. World Health Organization: Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Available from [http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf]
• 26. Verma S, Mahajan V. HIV-tuberculosis co-infection. Int J Pulm Med 2008;10:1.
• 27. Sudjaritruk T, Maleesatharn A, Prasitsuebsai W, Fong SM, Le NO, Le TT, et al. Prevalence, Characteristics, Management, and Outcome of Pulmonary Tuberculosis in HIV-Infected Children in the TREAT Asia Pediatric HIV Observational Database (TApHOD). AIDS Patient Care STDS 2013;27:649-56.
• 28. Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014;14(Suppl 1):5.
• 29. No authors listed. Features of children perinataly infected with HIV-1 surviving longer than 5 years. Italian register for HIV infection in children. Lancet 1994;343:191-5.
• 30. Koralnik IJ. Approach to HIV-infected patients with central nervous system lesions http://www.uptodate.com/contents/approach-to-hivinfected-patients-with-central-nervous-system-lesions.
• 31. Redig, AJ, Berliner N. Pathogenesis and clinical implications of HIVrelated anemia in 2013. Hematology Am Soc Hematol Educ Program 2013:377- 81.
• 32. Rivera DM, Richard EF. Pediatric HIV Infection. Medscape. Uptodated: Nov 08, 2016. Available from http://emedicine.medscape.com/ article/965086-overview
• 33. Mueller BU. Cancers in children infected with the human immunodeficiency virus. Oncologist 1999;4:309-17.
• 34. Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR. Malignancy in Perinatally Human Immunodeficiency Virus-Infected Children in the United States. Pediatr Infect Dis J 2005;24:237-42.